{"id":200430,"name":"DAIICHI SANKYO INC","slug":"daiichi-sankyo-inc","state":"NJ","country":"United States of America","description":"Pharmaceutical Company","totalSpending":1120000,"filings":27,"yearlySpending":[{"year":2018,"income":30000},{"year":2020,"income":60000},{"year":2021,"income":230000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["FARRAGUT PARTNERS LLP"],"lobbyists":["JEFF MACKINNON","JEFFERY MORTIER","SARAH WALTER","JODY GALE","EDWARD WHITFIELD","J WALSH","KRISTEN O'NEILL","WILLIAM KRIEGER","KRISTEN BAUTZ","DYLAN MOORE","CONSTANTINE HINGSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Opioid Legislation and CMS payment issues","Issues related to abuse deterrent opioids.","Issues related to abuse deterrent opioids.","Issues relating to the coverage of treatments for iron deficiency anemia","Issues relating to the coverage of treatments for iron deficiency anemia"]}